Dopo l'orario di chiusura: 2.18

Neuraxis Inc (NRXS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Neuraxis Inc Borsa (NRXS) Ultime notizie

Neuraxis Inc (NRXS)

Neuraxis Inc Borsa (NRXS) Ultime notizie

Chronic Idiopathic Constipation Clinical Trials and Pipeline - openPR

Critical Contrast: NeurAxis (NASDAQ:NRXS) & Zynex (NASDAQ:ZYXI) - Defense World

Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR

Analyzing NeurAxis (NASDAQ:NRXS) and Masimo (NASDAQ:MASI) - Defense World

End Of January 2025 Portfolio Review - substack.com

FDA Clears NeurAxis’ Self-Inflating Balloon Device - MPO-mag

Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World

NeurAxis, Inc. Announces New Medical Policy Coverage with a Prominent Insurer for over Five Million Lives Across Multiple States - Marketscreener.com

UPDATENeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States - The Manila Times

NeurAxis Expands IBS Treatment Coverage to 51M Lives, Targets Youth Market with Novel Device - StockTitan

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States - The Manila Times

NeurAxis Announces New Medical Policy Coverage with Molina - GlobeNewswire

NeurAxis Expands Coverage for FDA-Cleared IBS Pain Device to 51M Lives with Molina Deal - StockTitan

Intapp to announce fiscal second quarter 2025 financial results on February 4, 2025 - The Manila Times

NeurAxis announces Q4 preliminary unaudited revenues were about $800 thousand - MSN

Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR

Critical Analysis: Precision Optics (NASDAQ:POCI) & NeurAxis (NASDAQ:NRXS) - Defense World

Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors - The Manila Times

NeurAxis Inc. Issues Letter to Shareholders - GlobeNewswire

NeurAxis IB-Stim Reaches Major Milestone: Insurance Coverage Surges to 51 Million Lives, FDA Expands Age Range - StockTitan

AAR Corporation (NYSE: AIR) Issues Press Release and Slide Presentation on Q2 2025 Financial Results - Defense World

Amplitude Healthcare Acquisition (OTCMKTS:AMHCU) Announces Positive Preliminary Data from Jasper Therapeutics, Inc. BEACON Phase 1b/2a StudyOn January 8, 2025, Jasper Therapeutics, Inc. released a press release detailing encouraging preliminar - Defense World

NeurAxis, Inc. Reports Strong Preliminary Unaudited Fourth Quarter 2024 Results - Defense World

NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year - Marketscreener.com

Everything Blockchain Inc. Announces Letter to Shareholders from CEO - The Manila Times

NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth - GlobeNewswire

NeurAxis Q4 Revenue Surges 50% as IB-Stim Coverage Reaches 45 Million Lives - StockTitan

NeurAxis (NASDAQ:NRXS) Shares Down 4.1% – What’s Next? - Defense World

Model N Appoints New Chief Executive Officer, Bret Connor - The Manila Times

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - GlobeNewswire

NeurAxis CEO to Present at Lytham Partners 2025 Healthcare Investor Summit - StockTitan

MicroCap Opportunities 2024 Year-End Portfolio Update - substack.com

FDA Approvals News Live Feed - StockTitan

Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR

NeurAxis (NASDAQ:NRXS) Stock Price Down 5.3% – Here’s What Happened - Defense World

NeurAxis Inc. Announces FDA 510(k) Clearance of Red for Testing and Evaluation of Patients with Chronic Constipation - Marketscreener.com

Connyct Launches on iOS: Build Your College Crew, Share Your Vibe, and Never Miss a Party - The Manila Times

NeurAxis Inc. Announces FDA 510(k) Clearance of RED for - GlobeNewswire

NeurAxis Secures FDA Clearance for Revolutionary Chronic Constipation Testing Device - StockTitan

FDA Awards New Clearance to NeurAxis’ IB-Stim - MPO-mag

Rosalind Advisors, Inc. Acquires Significant Stake in Neuraxis I - GuruFocus.com

Neuraxis increases Series B Preferred Stock and extends dividend rights By Investing.com - Investing.com South Africa

Neuraxis increases Series B Preferred Stock and extends dividend rights - Investing.com

NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage - MSN

Critical Review: BioSig Technologies (NASDAQ:BSGM) vs. NeurAxis (NASDAQ:NRXS) - Defense World

NeurAxis, Inc. (NASDAQ:NRXS) Q3 2024 Earnings Call Transcript - MSN

Neuraxis secures $5 million in preferred stock sale By Investing.com - Investing.com Nigeria

Neuraxis secures $5 million in preferred stock sale - Investing.com

Neuronetics Grants Inducement Awards to New Employees - MSN

NeurAxis Stock Surges After Strong Q3 Earnings And Expanded Coverage - Barchart

Simile a NRXS